OA11505A - Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty. - Google Patents
Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty. Download PDFInfo
- Publication number
- OA11505A OA11505A OA1200000290A OA1200000290A OA11505A OA 11505 A OA11505 A OA 11505A OA 1200000290 A OA1200000290 A OA 1200000290A OA 1200000290 A OA1200000290 A OA 1200000290A OA 11505 A OA11505 A OA 11505A
- Authority
- OA
- OAPI
- Prior art keywords
- phenyl
- oxo
- bone
- compound
- ethoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8946998P | 1998-06-16 | 1998-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11505A true OA11505A (en) | 2004-05-07 |
Family
ID=22217825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200000290A OA11505A (en) | 1998-06-16 | 2000-10-20 | Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty. |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1087764A1 (sk) |
| JP (1) | JP2002518326A (sk) |
| KR (1) | KR20010052852A (sk) |
| CN (1) | CN1301160A (sk) |
| AP (1) | AP9901582A0 (sk) |
| AR (1) | AR018869A1 (sk) |
| AU (1) | AU4054799A (sk) |
| BG (1) | BG105041A (sk) |
| BR (1) | BR9911324A (sk) |
| CA (1) | CA2335134A1 (sk) |
| CO (1) | CO5070587A1 (sk) |
| EA (1) | EA200001186A1 (sk) |
| GT (1) | GT199900087A (sk) |
| HN (1) | HN1999000097A (sk) |
| HR (1) | HRP20000859A2 (sk) |
| HU (1) | HUP0102505A3 (sk) |
| ID (1) | ID27599A (sk) |
| IL (1) | IL138630A0 (sk) |
| IS (1) | IS5691A (sk) |
| MA (1) | MA26652A1 (sk) |
| NO (1) | NO20006312L (sk) |
| OA (1) | OA11505A (sk) |
| PA (1) | PA8475901A1 (sk) |
| PE (1) | PE20000646A1 (sk) |
| PL (1) | PL344981A1 (sk) |
| SK (1) | SK18912000A3 (sk) |
| TN (1) | TNSN99124A1 (sk) |
| TR (1) | TR200003544T2 (sk) |
| WO (1) | WO1999065486A1 (sk) |
| ZA (1) | ZA993975B (sk) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2360103A1 (en) * | 1999-02-08 | 2000-08-17 | Robert Sladek | Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha |
| ATE346159T1 (de) | 2000-05-08 | 2006-12-15 | Pfizer Prod Inc | Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors |
| AU2001276608A1 (en) | 2000-08-30 | 2002-03-13 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
| IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| WO2006024931A2 (en) * | 2004-08-31 | 2006-03-09 | Pfizer Products Inc. | Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator |
| CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| BRPI0807046A2 (pt) | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
-
1999
- 1999-06-15 PA PA19998475901A patent/PA8475901A1/es unknown
- 1999-06-15 AR ARP990102848A patent/AR018869A1/es not_active Application Discontinuation
- 1999-06-15 HN HN1999000097A patent/HN1999000097A/es unknown
- 1999-06-15 PE PE1999000528A patent/PE20000646A1/es not_active Application Discontinuation
- 1999-06-15 AP APAP/P/1999/001582A patent/AP9901582A0/en unknown
- 1999-06-15 ZA ZA9903975A patent/ZA993975B/xx unknown
- 1999-06-16 HU HU0102505A patent/HUP0102505A3/hu unknown
- 1999-06-16 GT GT199900087A patent/GT199900087A/es unknown
- 1999-06-16 KR KR1020007014186A patent/KR20010052852A/ko not_active Application Discontinuation
- 1999-06-16 EA EA200001186A patent/EA200001186A1/ru unknown
- 1999-06-16 PL PL99344981A patent/PL344981A1/xx not_active Application Discontinuation
- 1999-06-16 MA MA25628A patent/MA26652A1/fr unknown
- 1999-06-16 SK SK1891-2000A patent/SK18912000A3/sk unknown
- 1999-06-16 ID IDW20002627A patent/ID27599A/id unknown
- 1999-06-16 WO PCT/IB1999/001117 patent/WO1999065486A1/en not_active Application Discontinuation
- 1999-06-16 AU AU40547/99A patent/AU4054799A/en not_active Abandoned
- 1999-06-16 IL IL13863099A patent/IL138630A0/xx unknown
- 1999-06-16 CO CO99037622A patent/CO5070587A1/es unknown
- 1999-06-16 CN CN99806237A patent/CN1301160A/zh active Pending
- 1999-06-16 BR BR9911324-4A patent/BR9911324A/pt not_active Application Discontinuation
- 1999-06-16 EP EP99923802A patent/EP1087764A1/en not_active Withdrawn
- 1999-06-16 TN TNTNSN99124A patent/TNSN99124A1/fr unknown
- 1999-06-16 JP JP2000554366A patent/JP2002518326A/ja active Pending
- 1999-06-16 CA CA002335134A patent/CA2335134A1/en not_active Abandoned
- 1999-06-16 TR TR2000/03544T patent/TR200003544T2/xx unknown
-
2000
- 2000-10-20 OA OA1200000290A patent/OA11505A/en unknown
- 2000-10-27 IS IS5691A patent/IS5691A/is unknown
- 2000-12-11 BG BG105041A patent/BG105041A/xx unknown
- 2000-12-12 NO NO20006312A patent/NO20006312L/no not_active Application Discontinuation
- 2000-12-14 HR HR20000859A patent/HRP20000859A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR018869A1 (es) | 2001-12-12 |
| HUP0102505A2 (hu) | 2001-11-28 |
| IL138630A0 (en) | 2001-10-31 |
| NO20006312D0 (no) | 2000-12-12 |
| ID27599A (id) | 2001-04-12 |
| ZA993975B (en) | 2000-12-15 |
| HRP20000859A2 (en) | 2001-04-30 |
| HN1999000097A (es) | 1999-11-03 |
| AU4054799A (en) | 2000-01-05 |
| AP9901582A0 (en) | 1999-06-30 |
| TR200003544T2 (tr) | 2001-04-20 |
| SK18912000A3 (sk) | 2001-10-08 |
| PE20000646A1 (es) | 2000-08-05 |
| JP2002518326A (ja) | 2002-06-25 |
| HUP0102505A3 (en) | 2002-12-28 |
| BR9911324A (pt) | 2001-04-03 |
| GT199900087A (es) | 2000-12-07 |
| BG105041A (en) | 2001-08-31 |
| MA26652A1 (fr) | 2004-12-20 |
| WO1999065486A1 (en) | 1999-12-23 |
| TNSN99124A1 (fr) | 2005-11-10 |
| PA8475901A1 (es) | 2000-05-24 |
| CO5070587A1 (es) | 2001-08-28 |
| KR20010052852A (ko) | 2001-06-25 |
| EA200001186A1 (ru) | 2001-06-25 |
| PL344981A1 (en) | 2001-11-19 |
| NO20006312L (no) | 2000-12-12 |
| IS5691A (is) | 2000-10-27 |
| CA2335134A1 (en) | 1999-12-23 |
| EP1087764A1 (en) | 2001-04-04 |
| CN1301160A (zh) | 2001-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2433476T3 (es) | Combinaciones que contienen inhibidores de la dipeptidilpeptidasa-IV y agentes 5 antidiabéticos | |
| ES2312169T3 (es) | Terapia combinada para osteoporosis. | |
| JP2003528135A (ja) | 糖尿病のランゲルハンス島シグナリングの改善方法及びその防止方法 | |
| US20070265187A1 (en) | Oral Formulations Comprising Bone Morphogenetic Proteins For Treating Metabolic Bone Diseases | |
| US6132774A (en) | Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone | |
| OA11505A (en) | Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty. | |
| US20020002137A1 (en) | Combination of growth hormone secretagogues and antidepressants | |
| WO1999065488A1 (en) | Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty | |
| EP0966968B1 (en) | Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2 | |
| JP2007505892A (ja) | 向上した成長障害の処置方法 | |
| CZ20004679A3 (cs) | Terapeutické kombinace (selektivních) modulátorů estrogenního receptoru (ŠERM) a prostředků podporujících sekreci růstového hormonu (GHS) pro léčbu muskuloskeletární fragility | |
| MXPA00012727A (en) | Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty | |
| CN101677983A (zh) | 用于预防由于使用PPAR-γ激动剂引起的有害作用的组合物 | |
| JPH04282313A (ja) | 血圧降下剤 | |
| CZ20004680A3 (cs) | Terapeutické kombinace (selektivních) modulátorů estrogenního receptorů (ŠERM) a prostředků podporujících sekreci růstového hormonu (GHS) pro léčbu muskuloskeletární fragility | |
| MXPA00012628A (en) | Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty | |
| MXPA00012728A (en) | Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone | |
| JPH10203995A (ja) | 抗骨粗鬆症剤 | |
| MXPA99005564A (en) | Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin e2 | |
| CN104586872A (zh) | 一种预防和治疗血管内皮功能紊乱的药物组合物及其应用 |